Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Dylan J. Dues, An Phu Tran Nguyen, Katelyn BeckeriD, Jiyan MaiD, Darren J. MooreiD
Abstract
Cognitive dysfunction is a salient feature of Parkinsons disease (PD) and Dementia with Lewy bodies (DLB). The onset of dementia reflects the spread of Lewy pathology throughout forebrain structures. The mere presence of Lewy pathology, however, provides limited indication of cognitive status. Thus, it remains unclear whether Lewy pathology is the de facto substrate driving cognitive dysfunction in PD and DLB. Through application of -synuclein fibrils in vivo, we sought to examine the influence of pathologic inclusions on cognition. Following stereotactic injection of -synuclein fibrils within the mouse forebrain, we measured the burden of -synuclein pathology at 1-, 3-, and 6-months post-injection within subregions of the hippocampus and cortex. Under this paradigm, the hippocampal CA2/3 subfield was especially susceptible to - synuclein pathology. Strikingly, we observed a drastic reduction of pathology in the CA2/3 subfield across time-points, consistent with the consolidation of -synuclein pathology into dense somatic inclusions followed by neurodegeneration. Silver-positive degenerating neurites were observed prior to neuronal loss, suggesting that this might be an early feature of fibril-induced neurotoxicity and a precursor to neurodegeneration. Critically, mice injected with -synuclein fibrils developed progressive deficits in spatial learning and memory. These findings support that the formation of -synuclein inclusions in the mouse forebrain precipitate neurodegenerative changes that recapitulate features of Lewy-related cognitive dysfunction. HighlightsO_LIMice injected with -synuclein fibrils develop hippocampal and cortical - synuclein pathology with a dynamic regional burden at 1-, 3-, and 6-months post-injection. C_LIO_LISilver-positive neuronal processes are an early and enduring degenerative feature of the fibril model, while extensive neurodegeneration of the hippocampal CA2/3 subfield is detected at 6-months post-injection. C_LIO_LIMice exhibit progressive hippocampal-dependent spatial learning and memory deficits. C_LIO_LIForebrain injection of -synuclein fibrils may be used to model aspects of Lewy-related cognitive dysfunction. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 27
- FWCI
- 4.59
- Field percentile
- top 4%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cortical α-synuclein pathology induces neuronal hypoactivity andcircuit changes but not functional impairments in a model of early Lewy body dementia
Aye Theint Theint, Noe Cazares, … William Zeiger·bioRxiv·Jul 31, 2025
- Cofilin pathology is a new player on α-synuclein-induced spine impairment in models of hippocampal synucleinopathy
Marina I. Oliveira da Silva, Miguel Santejo, … Márcia A. Liz·Cell Death and DiseasePeer-reviewed·Apr 13, 2024
- Alpha-synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures and lead to isolated behavioral symptoms
M. A. Weber, G. Kerr, … G. M. Aldridge·bioRxiv·Jan 31, 2023
- Microglial reactivity in the hippocampal CA2 is associated with advanced neuronal α-synucleinopathy
Esteban Luna, Katheryn A Q Cousins, … David John Irwin·bioRxiv·Feb 11, 2026
- Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein
Nolwazi Z. Gcwensa, Drèson L. Russell, … Laura A. Volpicelli‐Daley·Neurobiology of DiseasePeer-reviewed·Jul 5, 2024
- Lewy pathology accumulates in swollen corticostriatal synapses in α-synucleinopathies
Alice Prigent, Aastha Singh, Michael X. Henderson·Brain CommunicationsPeer-reviewed·Oct 23, 2026